More than half of patients with treatment-refractory hidradenitis suppurativa achieve meaningful disease improvement with golimumab therapy in a study.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/golimumab-shows-benefit-treatment-refractory-hidradenitis-2026a1000jfc?src=rss
Author :
Publish date : 2026-06-10 15:05:00
Copyright for syndicated content belongs to the linked Source.